.Pharmacolibrary.Drugs.S_SensoryOrgans.S01E_AntiglaucomaPreparationsAndMiotics.S01EX05_Netarsudil.Netarsudil .Pharmacolibrary.Drugs.S_SensoryOrgans.S01E_AntiglaucomaPreparationsAndMiotics.S01EX05_Netarsudil.Netarsudil| name: | Netarsudil | |
| ATC code: | S01EX05 | route: | ophthalmic |
| compartments: | 1 | |
| dosage: | 0.04 | mg |
| volume of distribution: | 1.5 | L |
| clearance: | 10 | L/h |
| other parameters in model implementation | ||
Netarsudil is a Rho kinase inhibitor used for the reduction of elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension. It is approved for topical ophthalmic use.
Pharmacokinetic parameters estimated for human subjects based on available product labeling and pharmacology reviews, as direct peer-reviewed pharmacokinetic profile studies are not published.